N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain

@article{Szab2021NNDimethyltryptamineAS,
  title={N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain},
  author={{\'I}risz Szab{\'o} and Vikt{\'o}ria {\'E}. Varga and Szabolcs Dvor{\'a}csk{\'o} and Attila E. Farkas and T{\'i}mea K{\"o}rm{\"o}czi and R{\'o}bert Berkecz and Szilvia Kecsk{\'e}s and {\'A}kos Menyh{\'a}rt and Rita Frank and D{\'o}ra Hantosi and Nicholas V Cozzi and Ede Frecska and Csaba T{\"o}mb{\"o}ly and Istvan A Krizbai and Ferenc Bari and Eszter Farkas},
  journal={Neuropharmacology},
  year={2021},
  volume={192}
}
Dimethyltryptamine (DMT), an endogenous ligand of sigma-1 receptors (Sig-1Rs), acts against systemic hypoxia, but whether DMT may prevent cerebral ischemic injury is unexplored. Here global forebrain ischemia was created in anesthetized rats and aggravated with the induction of spreading depolarizations (SDs) and subsequent short hypoxia before reperfusion. Drugs (DMT, the selective Sig-1R agonist PRE-084, the Sig-1R antagonist NE-100, or the serotonin receptor antagonist asenapine) were… Expand

Figures from this paper

From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders.
TLDR
Recent findings and information on how psychedelics may act therapeutically on cells within the Central Nervous System (CNS) during brain injuries and neurodegenerative diseases are discussed. Expand

References

SHOWING 1-10 OF 130 REFERENCES
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats
TLDR
The results indicate a Sig-1R dependent reduction of the ischemic brain injury following exogenous DMT administration in rats, presumably through a combined anti-apoptotic, pro-neurotrophic and anti-inflammatory treatment effect. Expand
The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells
TLDR
Results reveal a novel and important role of DMT in human cellular physiology and postulate that this compound may be endogenously generated in situations of stress, ameliorating the adverse effects of hypoxic/ischemic insult to the brain. Expand
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
TLDR
The immunomodulatory potential of NN-DMT and 5-MeO-D MT on human moDC functions via sigmar-1 that could be harnessed for the pharmacological treatment of autoimmune diseases and chronic inflammatory conditions of the CNS or peripheral tissues is demonstrated for the first time. Expand
The antagonism of prostaglandin FP receptors inhibits the evolution of spreading depolarization in an experimental model of global forebrain ischemia
TLDR
The antagonism of FP receptors (located at the neuro-vascular unit, neurons, astrocytes and microglia) emerges as a promising approach to inhibit the evolution of SDs in cerebral ischemia. Expand
Effects of the Sigma-1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-Phenylpropyl)-Piperazine Dihydro-Chloride on Inflammation after Stroke
TLDR
The results suggest that sigma-1 receptor activation affects Iba1 expression in microglia/macrophages of the ischemic hemisphere after experimental stroke but does not affect post-stroke inflammatory mediators. Expand
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of syntheticExpand
Cortical spreading depression-associated hyperemia in rats: involvement of serotonin
TLDR
Serotonin is, probably via 5-HT2 receptors, involved in the modulation of the regional cerebral blood flow increase during CSD, and novel highly selective receptor antagonists may help to discriminate the differential contribution of various 5- HT receptor subspecies. Expand
Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons
TLDR
The ability of sigma ligands to attenuate NMDA-, trans-ACPD- and KCl-evoked neuronal calcium dynamics indicates that the receptor mechanisms mediating sigma neuroprotection comprise complex interactions involving ionotropic, metabotropic, and even voltage-gated calcium signaling processes. Expand
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity
N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of plant origin. It has also been found in animal tissues and regarded as an endogenous trace amineExpand
Contribution of prostanoid signaling to the evolution of spreading depolarization and the associated cerebral blood flow response
TLDR
It is suggested, that activation of EP4 receptors initiates vasodilation in response to SD in the intact brain, and – together with COX-1 derived prostanoids – shortens SD duration in the acute phase of ischemia. Expand
...
1
2
3
4
5
...